Recent
price
P/E
ratio
div
yld
0.61%
ROIC.AI
Some doses of Lilly's Zepbound in short supply through April-end, US FDA says
Zepbound Is Officially in Shortage, FDA Says
Novo says Ozempic starter kits still not available in Germany in Q2
Tesla Rolls in With Its Worst Sales Miss Ever
Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note
Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note
Citigroup Pounds the Table on Eli Lilly Stock
US takes next step in Medicare drug price negotiations with pharma companies
Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
UPDATE 1-Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
Jim Cramer says Microsoft's unbundling of Teams and Office is good news for this portfolio stock
FDA website shows limited availability of some doses of Lilly's Mounjaro through April
Zepbound Patients Have a Solution for Obesity Drug Shortage: ‘Release the Vials’
Jim Cramer's top 10 things to watch in the stock market Tuesday
Eli Lilly’s Ozempic Competitors Face Risks. Why the Stock Has More Upside.
The Zacks Analyst Blog Highlights Apple, NVIDIA, Eli Lilly, American Tower and McKesson
Is It Too Late to Buy Eli Lilly Stock?
Top Stock Reports for Apple, NVIDIA & Eli Lilly
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.